Hormone receptor functional dimers and methods of their use

Details Hormone receptor functional dimers and methods of their use Hormone receptor functional dimers and methods of their use

2006-06-06

2006-06-06

Murphy, Joseph (Department: 1646)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

C435S069100, C435S320100, C435S325000, C536S023500

Reexamination Certificate

active

07057015

ABSTRACT:
The invention provides chimeric proteins having at least two functional protein units, each containing the dimerization domain of a member of the steroid/thyroid hormone nuclear receptor superfamily. The chimeric proteins can fold under crystallization conditions to form functional entities. The functional entities optionally contain a novel flexible peptide linker of variable lengths between at least two of the protein units. In a preferred embodiment, the linker is designed to be increased in increments of 12 amino acids each to aid in preparation of variant chimeric proteins. The DNA binding characteristics of the invention functional entities differ from those of wild-type complexes formed between “monomeric” receptors and their binding partners. Some functional entities, e.g. dimers expressed as fusion proteins, transactivate responsive promoters in a manner similar to wild-type complexes, while others do not promote transactivation and function instead essentially as constitutive repressors. The invention further provides nucleotide sequences encoding the invention chimeric proteins, cells containing such nucleotide sequences, and methods for using the invention chimeric proteins to modulate expression of one or more exogenous genes in a subject organism. In addition, isolated protein crystals suitable for x-ray diffraction analysis and methods for obtaining putative ligands for the invention chimeric proteins are provided.

REFERENCES:
patent: 4160452 (1979-07-01), Theeuwes
patent: 4256108 (1981-03-01), Theeuwes
patent: 4265874 (1981-05-01), Bonsen et al.
patent: 4394448 (1983-07-01), Szoka, Jr. et al.
patent: 4399216 (1983-08-01), Axel et al.
patent: 4405712 (1983-09-01), Vande Woude et al.
patent: 4619794 (1986-10-01), Hauser
patent: 4634665 (1987-01-01), Axel et al.
patent: 4650764 (1987-03-01), Temin et al.
patent: 4870009 (1989-09-01), Evans et al.
patent: 4952496 (1990-08-01), Studier et al.
patent: 4981784 (1991-01-01), Evans et al.
patent: 5024939 (1991-06-01), Gorman
patent: 5252479 (1993-10-01), Srivastava
patent: 5399346 (1995-03-01), Anderson et al.
patent: 5599904 (1997-02-01), Evans et al.
patent: 5830462 (1998-11-01), Crabtree et al.
patent: 6265173 (2001-07-01), Evans et al.
patent: 6268158 (2001-07-01), Pantoliano et al.
patent: WO 89/05345 (1989-06-01), None
patent: WO 90/06997 (1990-06-01), None
patent: WO 92/05266 (1992-04-01), None
patent: WO 92/07573 (1992-05-01), None
patent: WO 92/14829 (1992-09-01), None
patent: WO 99/10510 (1999-03-01), None
Aranda A, Pascual A. Nuclear hormone receptors and gene expression. Physiol Rev. 2001 Jul;81(3):1269-304.
Lees JA et al. A 22-amino-acid peptide restores DNA-binding activity to dimerization-defective mutants of the estrogen receptor. Mol Cell Biol. Oct. 1990;10(10):5529-31.
Peters GA, Khan SA. Estrogen receptor domains E and F: role in dimerization and interaction with coactivator RIP-140. Mol Endocrinol. Feb. 1999;13(2):286-96.
Hutchens TW et al. Mol Endocrinol. Feb. 1990;4(2):255-67.
Apoptosis, The Molecular Basis of Cell Death,Current Communications In Cell & Molecular Biology, Cold Spring Harbor Laboratory Press, 1991.
Bosselman et al., “Replication-Defective Chimeric Helper Proviruses and Factors Affecting Generation of Competent Virus: Expression of Moloney Murine Leukemia Virus Structural Genes via the Metallothionein Promoter”Molecular and Cellular Biology7(5):1797-1806 (1987).
Brent and Ptashne, “A Eukaryotic Transcriptional Activator Bearing the DNA Specificity of a Prokaryotic Repressor,”Cell, 43:729-736 (1985).
Christopherson et al., “Ecdysteroid-dependent regulation of genes in mammalian cells by aDrosophilaecdysone receptor and chimeric transactivators”Proc. Natl. Acad. Sci. USA, 89:6314-6318 (1992).
Conaway and Conaway, 1994, “Transcription Mechanisms and Regulation”,Raven Press Series on Molecular and Cellular Biology,vol. 3, Raven Press, Ltd., New York, NY.
Danos et al., “Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges”Proc. Natl. Acad. Sci. USA85:6460-6464 (1988).
Devlin et al., “Random Peptide Libraries: A Source of Specific Protein Binding Molecules”Science, 249:404-406 (1990).
Evans R.M., “The Steroid and Thyroid Hormone Receptor Superfamily”Science240:889-895 (1988).
Forman et al., “Identification of a Nuclear Receptor That Is Activated by Farnesol Metabolites”Cell81:687-693 (1995).
Freedman et al., “The function and structure of the metal coordination sites within the glucocorticoid receptor DNA binding domain”Nature334:543-546 (1988).
Friedmann, T., “Progress Toward Human Gene Therapy”Science244:1275-1281 (1989).
Furth et al., “Temporal control of gene expression in transgenic mice by a tetracylcline-responsive promoter”Proc. Natl. Acad. Sci. USA91: 9302-9306 (1994).
Giguere et al., “Identification of a receptor for the morphogen retinoic acid”Nature330:624-629 (1987).
Glass et al., “Thyroid Hormone Receptor Binds with Opposite Transcriptional Effects to a Common Sequence Motif in Thyroid Hormone and Estrogen Response Elements”Cell54:313-323 (1988).
Gossen et al., “Control of gene activity in higher eukaryotic cells by prokaryotic regulatory elements”TIBS18:471-475 (1993).
Gossen et al., “Tight Control of gene expression in mammalian cells by tetracycline-responsive promoters”Proc. Natl. Acad. Sci.89:5547-5551 (1992).
Gossen et al., “Transcriptional Activation by Tetracyclines in Mammalian Cells”Science268:1766-1769 (1995).
Green and Chambon, “Nuclear receptor enhance our understanding of transcription regulation”Trends Genet.4:309-314 (1988).
Green and Chambon, “Oestradiol induction of a glucocortiocoid-responsive gene by a chimaeric receptor”Nature325:75-78 (1987).
Harrison, “A structural taxonomy of DNA-binding domains”Nature353:715-719.
Hollenberg and Evans, “Multiple and Cooperative Trans-Activation Domains of the Human Glucocorticoid Receptor”Cell55:899-906 (1988).
Jacobs and Michaels, “Zinc Finger Gene Database”The New Biologist2(6):583 (1990).
Jacobs, G.H., “Determination of the base recognition positions of zinc fingers from sequence analysis”The EMBO Journal11:4507-4517 (1992).
Jaenisch, R., “Transgenic Animals”Science240:1468-1474 (1988).
Kamine et al., “Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein”Proc. Natl. Acad. Sci. USA88:8510-8514 (1991).
Klock et al., “Oestrogen and glucocorticoid responsive elements are closely related but distinct”Nature329:734-736 (1987).
Klug and Rhodes, ‘Zince fingers’: a novel protein motif for nucleic acid recognitionTIBS12:464-469 (1987).
Koelle et al., “TheDrosophila EcRGene Encodes an Ecdysone Receptor, a New Member of the Steroid Receptor Superfamily”Cell67:59-77 (1991).
Kumar and Chambon, “The Estrogen Receptor Binds Tightly to its Responsive Element as a Ligand-Induced Homodimer”Cell55:145-156 (1988).
Kumar et al., “Functional Domains of the Human Estrogen Receptor”Cell51:941-951 (1987).
Ladias et al., “Regulation of the Apolipoprotein AI Gene by ARP-1, a Novel Member of the Steroid Receptor Superfamily”Science251:561-565 (1991).
Lee et al., CD8 Surface Levels Alter the Fate of α/β T Cell Receptor-expressing Thymocytes in Transgenic MiceJ. Exp. Med.175:1013-1025 (1992).
Leonard et al., “Charaterization of Somatostatin Transactivating Factor-1, a Novel Homeobox Factor That Stimulates Somatostatin Expression in Pancreatic Islet Cells”Molecular Endocrinology7(10):1275-1283.
Mangelsdorf et al., “The Retinoid Receptors”The Retinoids: Biology, Chemistry, and Medicine, 2nd Edition8:319-349 (1994).
Markowitz, et al. “A Safe Packaging Line for Gene Transfer: Sep

Affiliated with

Also associated with

Rating

Hormone receptor functional dimers and methods of their use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hormone receptor functional dimers and methods of their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hormone receptor functional dimers and methods of their use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3651573